官方服务：
资源简介：
monitor lung cancer patients plasma ctDNA mutations
应用场景：
创建时间：
2017-05-11
相关数据集
Additional file 12 of Detection and characterization of pancreatic and biliary tract cancers using cell-free DNA fragmentomics
Supplementary Material 12: Table S7. CF model performance.
NIAID Data Ecosystem50
Frequency and coverage of promoter methylation in plasma and serum cfDNA.
aCoverage: percentage of cases with methylation in at least one gene in the given panel (i.e., coverage of 100% means that all samples had methylation of at least one gene in the panel). *The patholog
NIAID Data Ecosystem30
Patient and tumor characteristics (n = 14).
BackgroundWe prospectively investigated the potential of tumor-informed circulating tumor DNA (ctDNA) for detecting minimal residual disease (MRD) in surgically resected biliary tract cancer (BTC).Met
Figshare2026-01-21 更新10
DataSheet_3_RNA Sequencing of Tumor-Educated Platelets Reveals a Three-Gene Diagnostic Signature in Esophageal Squamous Cell Carcinoma.xlsx
There is no cost-effective, accurate, and non-invasive method for the detection of esophageal squamous cell carcinoma (ESCC) in clinical practice. We aimed to investigate the diagnostic potential of t
NIAID Data Ecosystem50
Clusters and speckled aCTC at baseline and follow-up samples from breast, colorectal and prostate cancer patients with ≥5 aCTC.
Cluster of aCTC defined as two or more DNA-DAPI objects within their CK-PE outline Speckled aCTC defined as more than two dot-like structures in their CK-PE outline.
NIAID Data Ecosystem20
